Annual SGA
$8.69 M
-$15.00 K-0.17%
December 31, 2023
Summary
- As of February 7, 2025, CKPT annual SGA is $8.69 million, with the most recent change of -$15.00 thousand (-0.17%) on December 31, 2023.
- During the last 3 years, CKPT annual SGA has risen by +$767.00 thousand (+9.69%).
- CKPT annual SGA is now -0.17% below its all-time high of $8.70 million, reached on December 31, 2022.
Performance
CKPT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.36 M
+$1.12 M+50.31%
September 30, 2024
Summary
- As of February 7, 2025, CKPT quarterly SGA is $3.36 million, with the most recent change of +$1.12 million (+50.31%) on September 30, 2024.
- Over the past year, CKPT quarterly SGA has increased by +$1.12 million (+50.18%).
- CKPT quarterly SGA is now at all-time high.
Performance
CKPT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.31 B
-$46.47 M-3.67%
September 30, 2024
Summary
- As of February 7, 2025, CKPT TTM SGA is -$1.31 billion, with the most recent change of -$46.47 million (-3.67%) on September 30, 2024.
- Over the past year, CKPT TTM SGA has dropped by -$1.32 billion (-14234.45%).
- CKPT TTM SGA is now -9353.15% below its all-time high of -$13.89 million.
Performance
CKPT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CKPT Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -0.2% | +50.2% | -10000.0% |
3 y3 years | +9.7% | +81.9% | -10000.0% |
5 y5 years | +31.8% | +100.1% | -10000.0% |
CKPT Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -0.2% | +1.7% | at high | +81.9% | -93.5% | at low |
5 y | 5-year | -0.2% | +20.1% | at high | +100.1% | -199.3% | at low |
alltime | all time | -0.2% | +249.1% | at high | +1433.3% | -9353.1% | at low |
Checkpoint Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $3.36 M(+50.3%) | $9.92 M(+12.8%) |
Jun 2024 | - | $2.23 M(-8.9%) | $8.80 M(-0.5%) |
Mar 2024 | - | $2.45 M(+30.7%) | $8.84 M(+1.8%) |
Dec 2023 | $8.69 M(-0.2%) | $1.88 M(-16.1%) | $8.69 M(-6.5%) |
Sep 2023 | - | $2.24 M(-2.0%) | $9.29 M(+4.4%) |
Jun 2023 | - | $2.28 M(-0.5%) | $8.90 M(+1.7%) |
Mar 2023 | - | $2.29 M(-7.7%) | $8.75 M(+0.6%) |
Dec 2022 | $8.70 M(+1.9%) | $2.48 M(+34.5%) | $8.70 M(+4.2%) |
Sep 2022 | - | $1.85 M(-13.3%) | $8.35 M(-0.9%) |
Jun 2022 | - | $2.13 M(-5.1%) | $8.42 M(+0.2%) |
Mar 2022 | - | $2.24 M(+5.4%) | $8.41 M(-1.5%) |
Dec 2021 | $8.54 M(+7.8%) | $2.13 M(+10.7%) | $8.54 M(+0.0%) |
Sep 2021 | - | $1.92 M(-9.0%) | $8.53 M(-5.6%) |
Jun 2021 | - | $2.11 M(-10.9%) | $9.04 M(+5.0%) |
Mar 2021 | - | $2.37 M(+11.7%) | $8.61 M(+8.8%) |
Dec 2020 | $7.92 M | $2.12 M(-12.6%) | $7.92 M(-0.4%) |
Sep 2020 | - | $2.43 M(+44.0%) | $7.95 M(+11.3%) |
Jun 2020 | - | $1.69 M(+0.5%) | $7.14 M(-1.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $1.68 M(-22.0%) | $7.21 M(-0.3%) |
Dec 2019 | $7.23 M(+9.7%) | $2.15 M(+32.8%) | $7.23 M(+9.9%) |
Sep 2019 | - | $1.62 M(-7.8%) | $6.58 M(+1.2%) |
Jun 2019 | - | $1.76 M(+3.2%) | $6.51 M(+6.7%) |
Mar 2019 | - | $1.70 M(+13.4%) | $6.10 M(-7.4%) |
Dec 2018 | $6.59 M(+21.6%) | $1.50 M(-2.7%) | $6.59 M(+2.3%) |
Sep 2018 | - | $1.54 M(+14.2%) | $6.45 M(+3.2%) |
Jun 2018 | - | $1.35 M(-38.4%) | $6.25 M(+0.6%) |
Mar 2018 | - | $2.19 M(+61.9%) | $6.21 M(+14.6%) |
Dec 2017 | $5.42 M(+21.3%) | $1.35 M(+0.8%) | $5.42 M(+5.1%) |
Sep 2017 | - | $1.34 M(+2.1%) | $5.15 M(+7.8%) |
Jun 2017 | - | $1.32 M(-6.1%) | $4.78 M(+2.0%) |
Mar 2017 | - | $1.40 M(+28.7%) | $4.69 M(+4.9%) |
Dec 2016 | $4.47 M(+79.5%) | $1.09 M(+12.1%) | $4.47 M(-19.3%) |
Sep 2016 | - | $972.00 K(-20.4%) | $5.53 M(+15.8%) |
Jun 2016 | - | $1.22 M(+3.1%) | $4.78 M(+34.3%) |
Mar 2016 | - | $1.18 M(-45.1%) | $3.56 M(+49.9%) |
Dec 2015 | $2.49 M | $2.16 M(+884.5%) | $2.38 M(+984.5%) |
Sep 2015 | - | $219.00 K | $219.00 K |
FAQ
- What is Checkpoint Therapeutics annual SGA?
- What is the all time high annual SGA for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics annual SGA year-on-year change?
- What is Checkpoint Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly SGA year-on-year change?
- What is Checkpoint Therapeutics TTM SGA?
- What is the all time high TTM SGA for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics TTM SGA year-on-year change?
What is Checkpoint Therapeutics annual SGA?
The current annual SGA of CKPT is $8.69 M
What is the all time high annual SGA for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high annual SGA is $8.70 M
What is Checkpoint Therapeutics annual SGA year-on-year change?
Over the past year, CKPT annual SGA has changed by -$15.00 K (-0.17%)
What is Checkpoint Therapeutics quarterly SGA?
The current quarterly SGA of CKPT is $3.36 M
What is the all time high quarterly SGA for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high quarterly SGA is $3.36 M
What is Checkpoint Therapeutics quarterly SGA year-on-year change?
Over the past year, CKPT quarterly SGA has changed by +$1.12 M (+50.18%)
What is Checkpoint Therapeutics TTM SGA?
The current TTM SGA of CKPT is -$1.31 B
What is the all time high TTM SGA for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high TTM SGA is -$13.89 M
What is Checkpoint Therapeutics TTM SGA year-on-year change?
Over the past year, CKPT TTM SGA has changed by -$1.32 B (-14234.45%)